AUA 2021: State-of-the-art Lecture: First and Second Line Therapy in Advanced and Metastatic Bladder Cancer: A Changing Paradigm
AUA 2021 First and Second Line Therapy in Advanced and Metastatic Bladder Cancer, metastatic urothelial cancer, MVAC chemotherapy, checkpoint immunotherapy, platinum-refractory advanced UC, Keynote-045 study, IMvigor130 trial, DANUBE trial, KEYNOTE-361 trial.
Source: urotoday.com